The MOA trial (Management of Osteoarthritis, or Maimoatanga Mate Köiwi) was a randomised clinical trial that aimed to investigate the long-term effectiveness and cost-effectiveness of both a multi-modal, individualised, ...

Osteoarthritis (OA) is a leading cause of health losses and costs in NZ. The burden of OA is rising as a result of population ageing, rising obesity, increasing injury rates, and earlier onset of disease. The New Zealand ...

The research outputs featured in this abridged selection provide evidence regarding the burdent of osteoarthritis in the NZ adult population, and the effectiveness, cost-effectiveness, and stakeholder acceptability of ...